These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36575044)

  • 21. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
    Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lidocaine inhibits the proliferation and invasion of hepatocellular carcinoma by downregulating USP14 induced PI3K/Akt pathway.
    Zhang Y; Jia J; Jin W; Cao J; Fu T; Ma D; Zhang Y
    Pathol Res Pract; 2020 Aug; 216(8):152963. PubMed ID: 32471606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.
    Zhu L; Sun Y; Zhang S; Wang L
    Mol Cell Biochem; 2020 Mar; 466(1-2):55-63. PubMed ID: 32052247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
    Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
    Zhang R; Ai J; Wang J; Sun C; Lu H; He A; Li M; Liao Y; Lei J; Zhou F; Wu L; Liao W
    J Transl Med; 2022 Jul; 20(1):325. PubMed ID: 35864529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.
    Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MiR-372-5p regulates PI3K/AKT/CXCL12 signaling pathway by targeting PTEN to promote colorectal cancer cell metastasis].
    Shi X; Wei K; Wu Y; Wang W; Yang Q; Chen C
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1191-1197. PubMed ID: 36073218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT.
    Zheng Z; Zhang Y; Zhang Z; Yang Y; Song T
    Med Sci Monit; 2017 Mar; 23():1277-1285. PubMed ID: 28288092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
    Chai C; Song LJ; Han SY; Li XQ; Li M
    CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1.
    Han L; Wang Y; Sun S
    Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of GAS5 promoted invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells via miR-21/PTEN/Akt axis].
    Xiong BH; Li SS; Ren ZY; Zhang Z; Liu YZ; Sun Y; Chi JL; Luo HY
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1168-1174. PubMed ID: 36380665
    [No Abstract]   [Full Text] [Related]  

  • 37. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.
    Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
    Tumour Biol; 2014 Jun; 35(6):5189-98. PubMed ID: 24573607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin.
    Yang Y; Cheng T; Xie P; Wang L; Chen H; Cheng Z; Zhou J
    Drug Dev Res; 2022 Feb; 83(1):64-74. PubMed ID: 34189738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.